阿尔茨海默病数据镜头:阿尔茨海默病研究的开放数据分析门户
Ayush Noori1, Rojashree Jayakumar1, Vaishnavi Moturi1
1Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.
Journal of Alzheimer's disease : JAD
|February 2, 2024
概括
阿尔茨海默病数据提供了一个集中式的,基于网络的门户网站,用于探索各种阿尔茨海默病 (AD) omics 数据集. 这个资源增强了神经科学家查询和可视化复杂的遗传和转录基因数据用于AD研究的能力.
科学领域:
- 神经科学是一个神经科学.
- 基因组学就是基因组学.
- 生物信息学是一种生物信息学.
背景情况:
- 阿尔茨海默病 (AD) 研究越来越依赖于大规模的奥米克研究.
- 目前,神经科学家们缺乏一个统一的,可访问的平台来查询和可视化AD omics数据.
研究的目的:
- 开发一个在线门户网站,阿尔茨海默病数据镜头 (Alzheimer DataLENS),用于访问和分析与阿尔茨海默病研究相关的公共信息数据集.
主要方法:
- 使用R Shiny平台开发了一个基于Web的门户.
- 在人类队伍中对阿尔茨海默氏病的综合公开可用的转录学和遗传学研究.
- 通过统一的生物信息管道处理所有数据集,以实现一致的数据表示.
主要成果:
- 阿尔茨海默氏症DataLENS托管单核RNA测序,大量RNA测序 (跨越19个大脑区域和3个队伍),以及全基因组关联研究 (GWAS) 数据.
- 提供各种可视化,包括泡图,热图,UMAP图,盒子图,蛋白质-蛋白质相互作用网络和曼哈顿图.
- 提供了链接到AD进度地图和天体细胞地图以供进一步探索.
结论:
- 阿尔茨海默氏症数据镜头 (Alzheimer DataLENS) 为研究人员提供了一个有价值的,免费可访问的资源.
- 能够系统和高效地探索用于阿尔茨海默病调查的OMIC数据集.
相关概念视频
01:26Alzheimer's Disease: Overview
487
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
487
01:30Dementia
115
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
115
01:22Alzheimer's Disease: Treatment
193
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
193